Back to search results

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Recurrent Meningioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Joshua D. Palmer, MD) · Joshua.Palmer@osumc.edu · 614-293-0871
    Contact: Principal Investigator (Joshua D. Palmer, MD)
Study leads

  • Joshua D Palmer, MD

    Principal Investigator

    Ohio State University Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)